Radnet Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $2.3B+24.0% YoYTTM through 30 Jun 2026
Net Income -$21.1M-856.0% YoYTTM through 30 Jun 2026
Free Cash Flow $85.6MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| EBITDA Margin | 10.7% |
| Operating Margin | 3.0% |
| Net Margin | -0.9% |
Returns
-3.1%ROE
-0.5%ROA
-1.2%ROIC
Balance Sheet Health
Debt / Equity0.81x
Current Ratio1.48x
Net Debt$634.7M
Cash & Equivalents$726.3M
Quality Metrics
Altman Z-Score1.88
Piotroski F-Score4 / 9
FCF Margin3.8%
Rule of 4014.3
Earnings-Beat Rate50.0%
Multi-Year Trend
RevenueFY2025: $2B
Diluted EPS-$0.26TTMFY2025: $-0.25
Dividend
No dividend
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Digital Health | $92.7M | +41.1% | View detailsFocused on developing improved medical interpretation of scans within Clinical AI for mammography, lung, prostate, and ultrasound imaging AI. |
| Imaging Center | $1.9B | View detailsCore outpatient imaging center operations continue to expand through de novo openings and strategic joint ventures. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.